Extracellular ATP Triggers Tumor Necrosis Factor‐α Release from Rat Microglia

Abstract: Brain microglia are a major source of inflammatory cytokines, such as tumor necrosis factor‐α (TNF‐α), which have been implicated in the progression of neurodegenerative diseases. Recently, microglia were revealed to be highly responsive to ATP, which is released from nerve terminals, activated immune cells, or damaged cells. It is not clear, however, whether released ATP can regulate TNF‐α secretion from microglia. Here we demonstrate that ATP potently stimulates TNF‐α release, resulting from TNF‐α mRNA expression in rat cultured brain microglia. The TNF‐α release was maximally elicited by 1 mM ATP and also induced by a P2X7 receptor‐selective agonist, 2′‐ and 3′‐O‐(4‐benzoylbenzoyl)adenosine 5′‐triphosphate, suggesting the involvement of P2X7 receptor. ATP‐induced TNF‐α release was Ca2+‐dependent, and a sustained Ca2+ influx correlated with the TNF‐α release in ATP‐stimulated microglia. ATP‐induced TNF‐α release was inhibited by PD 098059, an inhibitor of extracellular signal‐regulated protein kinase (ERK) kinase 1 (MEK1), which activates ERK, and also by SB 203580, an inhibitor of p38 mitogen‐activated protein kinase. ATP rapidly activated both ERK and p38 even in the absence of extracellular Ca2+. These results indicate that extracellular ATP triggers TNF‐α release in rat microglia via a P2 receptor, likely to be the P2X7 subtype, by a mechanism that is dependent on both the sustained Ca2+ influx and ERK/p38 cascade, regulated independently of Ca2+ influx.

[1]  J. Neary,et al.  Mitogenic Signaling by ATP/P2Y Purinergic Receptors in Astrocytes: Involvement of a Calcium-Independent Protein Kinase C, Extracellular Signal-Regulated Protein Kinase Pathway Distinct from the Phosphatidylinositol-Specific Phospholipase C/Calcium Pathway , 1999, The Journal of Neuroscience.

[2]  D. Ferrari,et al.  P2X7/P2Z Purinoreceptor-mediated Activation of Transcription Factor NFAT in Microglial Cells* , 1999, The Journal of Biological Chemistry.

[3]  D. Ferrari,et al.  P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death , 1999, FEBS letters.

[4]  M. Mattson,et al.  Ischemic and Excitotoxic Brain Injury is Enhanced in Mice Lacking the p55 Tumor Necrosis Factor Receptor , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  K. Inoue The functions of ATP receptors in the hippocampus. , 1998, Pharmacological research.

[6]  G Burnstock,et al.  Receptors for purines and pyrimidines. , 1998, Pharmacological reviews.

[7]  S. Koizumi,et al.  ATP stimulation of Ca2+‐dependent plasminogen release from cultured microglia , 1998, British journal of pharmacology.

[8]  E. Schaefer,et al.  Activation of p38MAPK in Microglia After Ischemia , 1998, Journal of neurochemistry.

[9]  E. Joe,et al.  Mitogen‐activated protein kinases activated by lipopolysaccharide and β‐amyloid in cultured rat microglia , 1998 .

[10]  John C. Lee,et al.  Extracellular Signal-Regulated Kinase and p38 Subgroups of Mitogen-Activated Protein Kinases Regulate Inducible Nitric Oxide Synthase and Tumor Necrosis Factor-α Gene Expression in Endotoxin-Stimulated Primary Glial Cultures , 1998, The Journal of Neuroscience.

[11]  Seamus J. Martin,et al.  Inhibition of TNF-induced apoptosis by NF-κB , 1998 .

[12]  D. Ferrari,et al.  Extracellular ATP Activates Transcription Factor NF-κB through the P2Z Purinoreceptor by Selectively Targeting NF-κB p65 (RelA) , 1997, The Journal of cell biology.

[13]  S. Yamamoto,et al.  Suppression of TNF-alpha secretion by azelastine in a rat mast (RBL-2H3) cell line: evidence for differential regulation of TNF-alpha release, transcription, and degranulation. , 1997, Journal of immunology.

[14]  D. Ferrari,et al.  ATP-mediated cytotoxicity in microglial cells , 1997, Neuropharmacology.

[15]  F. Di Virgilio,et al.  Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. , 1997, Journal of immunology.

[16]  P. Illés,et al.  Coexistence of purino‐ and pyrimidinoceptors on activated rat microglial cells , 1997, British journal of pharmacology.

[17]  M. Cobb,et al.  Mitogen-activated protein kinase pathways. , 1997, Current opinion in cell biology.

[18]  Rena Li,et al.  Inhibition of p75 Tumor Necrosis Factor Receptor by Antisense Oligonucleotides Increases Hypoxic Injury and β-Amyloid Toxicity in Human Neuronal Cell Line* , 1997, The Journal of Biological Chemistry.

[19]  Stefania Hanau,et al.  Purinergic Modulation of Interleukin-1 ␤ Release from Microglial Cells Stimulated with Bacterial Endotoxin Materials and Methods , 1997 .

[20]  G. Kreutzberg Microglia: a sensor for pathological events in the CNS , 1996, Trends in Neurosciences.

[21]  J. Merrill,et al.  Cytokines in inflammatory brain lesions: helpful and harmful , 1996, Trends in Neurosciences.

[22]  M. Mattson,et al.  Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors , 1996, Nature Medicine.

[23]  E. Kawashima,et al.  The Cytolytic P2Z Receptor for Extracellular ATP Identified as a P2X Receptor (P2X7) , 1996, Science.

[24]  F. Di Virgilio,et al.  Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. , 1996, Journal of immunology.

[25]  F. Di Virgilio,et al.  Role of the purinergic P2Z receptor in spontaneous cell death in J774 macrophage cultures. , 1996, Biochemical and biophysical research communications.

[26]  Philip R. Cohen,et al.  PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo(*) , 1995, The Journal of Biological Chemistry.

[27]  M. Mattson,et al.  Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[28]  A. Bridges,et al.  A synthetic inhibitor of the mitogen-activated protein kinase cascade. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Jerry L. Adams,et al.  A protein kinase involved in the regulation of inflammatory cytokine biosynthesis , 1994, Nature.

[30]  S. Koizumi,et al.  Modulatory effect of plasminogen on NMDA-induced increase in intracellular free calcium concentration in rat cultured hippocampal neurons , 1994, Neuroscience Letters.

[31]  R. Baumgartner,et al.  Secretion of TNF from a rat mast cell line is a brefeldin A-sensitive and a calcium/protein kinase C-regulated process. , 1994, Journal of immunology.

[32]  P. Gebicke-haerter,et al.  Characterization and transduction mechanisms of purinoceptors in activated rat microglia , 1994, British journal of pharmacology.

[33]  P. Gebicke-haerter,et al.  Characterization and possible function of adenosine 5′‐triphosphate receptors in activated rat microglia , 1994, British journal of pharmacology.

[34]  M. Mattson,et al.  Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis , 1994, Neuron.

[35]  S. Ilschner,et al.  Extracellular ATP activates a cation conductance and a K+ conductance in cultured microglial cells from mouse brain , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[36]  F. Di Virgilio,et al.  Oxidized ATP. An irreversible inhibitor of the macrophage purinergic P2Z receptor. , 1993, The Journal of biological chemistry.

[37]  K. Pfeffer,et al.  V delta 1+ subset of human gamma delta T cells responds to ligands expressed by EBV-infected Burkitt lymphoma cells and transformed B lymphocytes. , 1992, Journal of immunology.

[38]  E. Benveniste,et al.  Role of protein kinase C activity in tumor necrosis factor-alpha gene expression. Involvement at the transcriptional level. , 1992, Journal of immunology.

[39]  S. Ishiura,et al.  Identification of Elastase as a Secretory Protease from Cultured Rat Microglia , 1992, Journal of neurochemistry.

[40]  L. Buée,et al.  Elevated circulating tumor necrosis factor levels in Alzheimer's disease , 1991, Neuroscience Letters.

[41]  D. Dickson,et al.  Microglia in human disease, with an emphasis on acquired immune deficiency syndrome. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[42]  K. Akagawa,et al.  Inhibitory effect of peripheral myelin P2 protein on the proliferation of a tumor cell line , 1989 .

[43]  N. Takei,et al.  Characterization of microglia isolated from a primary culture of embryonic rat brain by a simplified method , 1989 .

[44]  V. Perry,et al.  Macrophages and microglia in the nervous system , 1988, Trends in Neurosciences.

[45]  J. Drapier,et al.  Interferon‐γ and tumor necrosis factor induce the L‐arginine‐dependent cytotoxic effector mechanism in murine macrophages* , 1988 .

[46]  C. Brosnan,et al.  Hypothesis: A role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis , 1988, Journal of Neuroimmunology.

[47]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[48]  B. Gomperts,et al.  ATP induces nucleotide permeability in rat mast cells , 1979, Nature.

[49]  T. Böhm,et al.  Purinoceptor‐operated cationic channels in human B lymphocytes. , 1997, The Journal of physiology.

[50]  F. Di Virgilio The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death. , 1995, Immunology today.

[51]  H. Wanebo,et al.  Tumor necrosis factors. , 1989, Seminars in surgical oncology.